HYGEMED

Active

Private limited companyfounded 20223 yrs activeRoute d'Obourg 40, 7000 Mons, BelgiumKBO/BCE: BE 0792.401.215

Summary

The computed 12-month bankruptcy probability of HYGEMED is 1.8% (moderate). The 2025 annual accounts show equity of €318k and a net result of €97k. Equity is growing by ~46.8% per year across the filed fiscal years. Its solvency ranks better than 68% of 10359 sector peers (fiscal year 2025). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals.

Watch Print / PDF

Checked score

Score 2025

78 / 100

Excellent

The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.

Axes · tick = 2024

Profitability90▲+5

Solvency81▲+30

Growth78=

Track record94

Bankruptcy probability, 12 months

1.8% Moderate

0%0.5%1.5%4%10%≥ 25%

Credit up to €24k at 30 days acceptable

Liquidity ample (current ratio 2.23 against 1.34 in 2024; short-term debt: 44.2% and cash: 60.4% of total assets), and 44.2% of the assets are financed with debt.

How do we compute the score and the probability?

Credit advice for your own amount and term

Signals

Five signals. The signal on the left, the evidence on the right.

−lowers risk+raises risk○neutral

Limited track record

This company has not been active as long as an established one and statistically fails somewhat more often.

KBO · incorporation date

Age against the risk zone

Higher-failure-rate sector

In this sector companies fail more often than the Belgian average.

Gazette · bankruptcies per sector, NACE 47

Relative position

BE, all sectors

reference

Sector 47

higher

← fewer bankruptcies more bankruptcies →

Annual accounts: healthy financial profile

The latest annual accounts show a healthy profile in solvency, result and liquidity.

NBB · annual accounts 2025

Solvency, return and age of the figures

Solvency

55.8%

Return on assets

17.1%

Age of the figures

9 mo

Higher-failure-rate region

In this region companies fail more often than in the rest of the country.

KBO · registered office

Filed after the deadline

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 18-08-2026, 18 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.

NBB · 3 filings

Deviation from the deadline

2025

18 d late

2024

28 d late

2023

30 d late

← before the deadline after the deadline →

Checked, nothing found (2)

The next deadline is still running

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.

Companies Code · seven months

Position in the running window

24-09-2026 today31-12-2026 close31-07-2027 deadline

No strike-offs in the KBO publications

We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.

KBO publications · our coverage

Financials · fiscal year 2025, abbreviated schema

Turnover

Not included in this filing

EBIT margin

Not included in this filing

Net result

€97k▼ 10.9%

2024 · €109k

2023: €51k 2024: €109k

2023 → 2025

Working capital

€310k▲ 46.1%

2024 · €212k

2023: €98k 2024: €212k

2023 → 2025

Multi-year overview

Every figure with its change against the year before

▲ rise ▼ fall

Line202320242025Trend

Equity€111k-€221k▲ 98.1%€318k▲ 44.1%

Operating result€71k-€151k▲ 113%€133k▼ 11.5%

Net result€51k-€109k▲ 113%€97k▼ 10.9%

Result per fiscal year

Operating resultNet result

The operating result falls in 2025; 2025 is 12% below 2024.

Balance-sheet composition

2025 in colour, 2024 as the grey bar beneath

Assets €570k

98.6%

Fixed assets €8k ▼ 6.7%

Current assets €562k ▼ 32.2%

Equity and liabilities €570k

55.8%

44.2%

Equity €318k ▲ 44.1%

Debt €252k ▼ 59.1%

Debt's share of the balance-sheet total falls from 73.6% to 44.2%. Equity is higher and debt is lower.

Key figures and ratios

2025 value · change against 2024

EBITDA

€138k▼

2024 · €156k

Cash flow

€102k▼

2024 · €114k

Current ratio

2.23▲

2024 · 1.34

Quick ratio

1.72▲

2024 · 1.01

Debt to equity

0.79▼

2024 · 2.79

ROE

30.6%▼

2024 · 49.5%

ROA

17.1%▲

2024 · 13.0%

Interest coverage

405.37▼

2024 · 557.18

Debt ≤ 1 year

€252k▼

2024 · €617k

Income taxes

€36k▼

2024 · €41k

Staff costs

€54k▲

2024 · €49k

Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Filed annual accounts As filed with the NBB · 2025 against 2024 · 43 lines

Balance sheet Code20242025

Assets

Total assets20/58€837k€570k▼

Fixed assets21/28€8k€8k▼

Intangible fixed assets21€3k€2k▼

Tangible fixed assets22/27€5k€5k▲

Plant, machinery and equipment23€3k€2k▼

Furniture and vehicles24€2k€4k▲

Financial fixed assets28€363€363=

Current assets29/58€829k€562k▼

Stocks and contracts in progress3€207k€128k▼

Stocks30/36€207k€128k▼

Amounts receivable within one year40/41€69k€89k▲

Trade receivables40€69k€89k▲

Other amounts receivable41-€56

Cash at bank and in hand54/58€549k€345k▼

Deferred charges and accrued income490/1€4k€917▼

Equity and liabilities

Total equity and liabilities10/49€837k€570k▼

Equity10/15€221k€318k▲

Contributions10/11€60k€60k=

Reserves13€161k€258k▲

Distributable reserves133€161k€258k▲

Amounts payable17/49€617k€252k▼

Amounts payable within one year42/48€617k€252k▼

Trade debts44€198k€75k▼

Suppliers440/4€198k€75k▼

Taxes, remuneration and social security45€63k€56k▼

Taxes450/3€58k€51k▼

Remuneration and social security454/9€5k€5k▼

Other amounts payable47/48€355k€121k▼

Income statement Code20242025

Remuneration, social security and pensions62€49k€54k▲

Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€5k€4k▼

Other operating charges640/8€3k€2k▼

Gross operating margin9900€208k€194k▼

Operating profit (loss)9901€151k€133k▼

Financial charges65/66B€280€340▲

Recurring financial charges65€280€340▲

Profit (loss) for the period before taxes9903€151k€133k▼

Income taxes67/77€41k€36k▼

Profit (loss) for the period9904€109k€97k▼

Profit (loss) for the period to be appropriated9905€109k€97k▼

Appropriation of the result

Profit (loss) to be appropriated9906€109k€97k▼

Transfer to equity691/2€109k€97k▼

To other reserves6921€109k€97k▼

Social balance

Average headcount (FTE)90871.91.7▼

The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Download as CSV

Timeline · acts, filings and financial milestones

All 5Financial 2Filings 3

Next filing, fiscal year 2026, expected by 31-07-2027

2026

18-08

NBB filing Annual accounts filed

fiscal year 2025 · abbreviated schema · 18 days late

2025

28-08

NBB filing Annual accounts filed

fiscal year 2024 · full schema · 28 days late

2024

31-12

Financial Highest result since 2023net €109k ▲113%

Operating result €151k, net result €109k, both a record.

31-12

Financial Equity above €200kEq €221k ▲98.1%

2 profitable years in a row build equity to €221k.

30-08

NBB filing Annual accounts filed

fiscal year 2023 · full schema · 30 days late

Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.

Directors · office · real estate

Directors

3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.

Location & real-estate footprint

Registered office, Mons · 1 establishment unit since 2022

establishment approximate The establishment unit on the map

Cannot be placed on the map

This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.

Route d'Obourg 407000 Mons

Ground area

1.3 ha

Building footprint

3,220 m²

Volume, LiDAR

24,059 m³

2 parcels, Wallonia · tallest building 13.2 m, ±4 floors. Linked by address, not a title deed.

1 establishment unit

HYGEMED

Rue de la Jonction lot C, 6220 FleurusWholesale of pharmaceutical and medical goods

since 20222.339.076.311

2 parcels

Wallonia 2 (100%)

Parcel (capakey)	Region	Area	Buildings	Height / fl.
52021C0318/00A008	Wallonia	6,697 m²	1 · 2,263 m²	11.8 m · 2 fl.
53404B0381/00H000	Wallonia	5,886 m²	1 · 957 m²	13.2 m · 4 fl.

Linked by address, not proof of ownership

Methodology

via registered seat: 1 · via establishment units: 1

2 of 2 parcels with an exact address match; the rest are indicative.

Linked through address data, this is not proof of ownership.

Similar companies · same sector, comparable size

Dendermonde · Eq €317k

Sint-Niklaas · Eq €316k

Orthocam

BE 0544.679.051

Grobbendonk · Eq €313k

Of 1,070 companies in sector 47741 we hold annual accounts for 644. 477 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector

Company data · Crossroads Bank

Identification

Legal formPrivate limited company

Founded13-10-2022

Fiscal year end31-12

Activities, NACEBEL 2025

46460Wholesale of pharmaceutical and medical goods

47741Retail sale of medical and orthopaedic goods, excluding prescription glasses and lenses

Sources

Crossroads Bank for EnterprisesNational Bank · 3 filingsAddress and cadastre registers

Scores and ratios are computed by Checked and are not a credit decision.

Contact details

1 entry

E-mail:ben@etransverse.be

Enterprise